Aarey Drugs & Pharmaceuticals Ltd. benchmarking: Perfomance to industry peers

Financial

	Aarey Drugs & Pharma	Oxygenta Pharma	Natural Capsules
Operational Metrics
Financials
5 yr Average ROE	4.4 %	15.02 %	9.1 %
5yr average Equity Multiplier	2.28	-1.71	1.91
5yr Average Asset Turnover Ratio	1.58	1.26	0.61
5yr Avg Net Profit Margin	1.23 %	-10.07 %	6.68 %
Price to Book	1.32	0.0	0.86
P/E	55.1	0.0	0.0
5yr Avg Cash Conversion Cycle	60.21 Days	-21.7 Days	25.72 Days
Inventory Days	21.8 Days	80.38 Days	27.47 Days
Days Receivable	122.43 Days	20.8 Days	125.88 Days
Days Payable	103.05 Days	154.17 Days	118.63 Days
5yr Average Interest Coverage Ratio	3.59	-3.16	7.96
5yr Avg ROCE	8.53 %	-3.19 %	10.02 %
5yr Avg Operating Profit Margin	1.54 %	-9.3 %	14.83 %
5 yr average Debt to Equity	0.22	-1.91	0.51
5yr CAGR Net Profit	-9.19 %	n/a	-38.15 %
5yr Average Return on Assets	1.94 %	-6.87 %	4.68 %
Shareholdings
Promoter Holding	44.8 %	57.95 %	51.26 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-5.23 %	45.62 %	-5.3 %
Change in Mutual Fund Holding (3 Yrs)	0.0	-0.04 %	0.0